BioSpecifics Technologies Corp.
BSTC
BSTC was delisted on the 1st of December, 2020.
83 hedge funds and large institutions have $152M invested in BioSpecifics Technologies Corp. in 2015 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 39 increasing their positions, 25 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
56% more repeat investments, than reductions
Existing positions increased: 39 | Existing positions reduced: 25
37% more capital invested
Capital invested by funds: $111M → $152M (+$41.5M)
5% more funds holding
Funds holding: 79 → 83 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCMC
RK Capital Management (Colorado)
Denver,
Colorado
|
+$5M |
| 2 |
JAM
JW Asset Management
Miami Beach,
Florida
|
+$2.62M |
| 3 |
Renaissance Technologies
New York
|
+$1.12M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1M |
| 5 |
Invesco
Atlanta,
Georgia
|
+$802K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
-$3.28M |
| 2 |
NI
Numeric Investors
Boston,
Massachusetts
|
-$2.7M |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$1.55M |
| 4 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$1.3M |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$667K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
Barclays
London,
United Kingdom
| $16K | -$34.7K | -814 | -73% |
|
77
Royal Bank of Canada
Toronto,
Ontario, Canada
| $16K | +$7.97K | +187 | +176% |
|
78
Bank of America
Charlotte,
North Carolina
| $9K | +$7.63K | +179 | New |
|
|
MTIP
79
Magee Thomson Investment Partners
San Diego,
California
| $8K | +$469 | +11 | +8% |
|
|
JG
80
Jefferies Group
New York
| $4K | +$3.67K | +86 | New |
|
81
SEI Investments
Oaks,
Pennsylvania
| $3K | +$2.17K | +51 | New |
|
82
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $172 | +$74.2K | +1,741 | +109% |
|
|
NI
83
Numeric Investors
Boston,
Massachusetts
| – | -$2.7M | -68,936 | Closed |
|
84
Millennium Management
New York
| – | -$525K | -13,400 | Closed |
|
|
PP
85
PDT Partners
New York
| – | -$227K | -5,800 | Closed |
|
86
AllianceBernstein
Nashville,
Tennessee
| – | -$31K | -800 | Closed |
|
87
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$1K | -7 | Closed |
|
BSTC Hedge Fund Activity: Q2 2015 in Review
83 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in BioSpecifics Technologies Corp. (BSTC) for Q2 2015, worth a combined $152M — up 37% from $111M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new BSTC positions and 5 closed out — a net gain of 4 holders — while 39 added to existing stakes and 25 trimmed.
The largest buyer was RK Capital Management (Colorado), opening a new position worth an estimated $5M. The largest seller was Northpointe Capital, cutting an estimated $3.28M.
- 83 institutional investors held BioSpecifics Technologies Corp. (BSTC) as of Q2 2015, up from 79 in Q1 2015.
- Funds reported $152M of BioSpecifics Technologies Corp. stock for Q2 2015, up 37% quarter-over-quarter.
- 9 funds opened new BioSpecifics Technologies Corp. positions in Q2 2015 and 5 closed out, a net change of +4 holders.
- The largest BioSpecifics Technologies Corp. buyer in Q2 2015 was RK Capital Management (Colorado), an estimated $5M added.
- The largest BioSpecifics Technologies Corp. seller in Q2 2015 was Northpointe Capital, an estimated $3.28M sold.
Based on aggregated 13F filings for Q2 2015.